These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8215581)

  • 1. A novel antigen of the dermal-epidermal junction defined by an anti-CD1b monoclonal antibody (NU-T2).
    Kanitakis J; Zambruno G; Wang YZ; Roche P; Berti E; Schmitt D
    Arch Dermatol Res; 1993; 285(6):313-21. PubMed ID: 8215581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of a new antigen of the dermal-epidermal junction (NU-T2 DEJ Ag) in junctional epidermolysis bullosa.
    Tadini G; Kanitakis J; Cavalli R; Schmitt D; Cambiaghi S; Berti E
    Arch Dermatol Res; 1995; 287(8):699-704. PubMed ID: 8554379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
    Gao SQ; Bystryn JC
    J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
    Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
    J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3d,g is present in normal human epidermal basement membrane.
    Basset-Seguin N; Dersookian M; Cehrs K; Yancey KB
    J Immunol; 1988 Aug; 141(4):1273-80. PubMed ID: 3135326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases.
    Hintner H; Stingl G; Schuler G; Fritsch P; Stanley J; Katz S; Wolff K
    J Invest Dermatol; 1981 Feb; 76(2):113-8. PubMed ID: 6161971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease.
    Chan LS; Fine JD; Briggaman RA; Woodley DT; Hammerberg C; Drugge RJ; Cooper KD
    J Invest Dermatol; 1993 Sep; 101(3):262-7. PubMed ID: 8370962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
    Lazarova Z; Yancey KB
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of extracellular and intracellular bullous pemphigoid antigens at the dermal-epibolic junction in organ culture of human skin.
    Ikeda S; Yaguchi H; Ogawa H
    J Invest Dermatol; 1990 Mar; 94(3):336-40. PubMed ID: 2407787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An acquired bullous dermatosis due to an autoimmune reaction against uncein.
    Horiguchi Y; Ueda M; Shimizu H; Tanaka T; Matsuyoshi N; Utani A; Ikai K; Nishikawa T; Imamura S
    Br J Dermatol; 1996 May; 134(5):934-8. PubMed ID: 8736340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of basement membrane zone antigens defined by antibodies that react to both the epidermal and dermal side of 1 M sodium chloride split skin.
    Niimi Y; Zhu ZX; Bystryn JC
    J Invest Dermatol; 1991 Aug; 97(2):312-7. PubMed ID: 1712821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
    Fine JD; Horiguchi Y; Couchman JR
    Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
    Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel 105-kDa lamina lucida autoantigen: association with bullous pemphigoid.
    Cotell SL; Lapiere JC; Chen JD; Iwasaki T; Krusinski PA; Chan LS; Woodley DT
    J Invest Dermatol; 1994 Jul; 103(1):78-83. PubMed ID: 8027584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae.
    Klein GF; Hintner H; Schuler G; Fritsch P
    Br J Dermatol; 1983 Nov; 109(5):499-508. PubMed ID: 6357262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
    Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
    Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
    Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Bröcker EB; Hashimoto T
    J Invest Dermatol; 1996 Mar; 106(3):465-70. PubMed ID: 8648178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes.
    Briggaman RA; Schechter NM; Fraki J; Lazarus GS
    J Exp Med; 1984 Oct; 160(4):1027-42. PubMed ID: 6384417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.